Official UK procurement notice
NP35923 Cardiovascular & Respiratory Medicines
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") (NHS & healthcare)
What is being bought18 lots · detail below
Published requirement descriptionThis Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods were split into eighteen (18) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
CPV: Pharmaceutical products
How this framework works
From the published notice- Bids received
- 43 bids on the busiest of 15 lots · 46 suppliers appointed
Lots and requirements (18)Procurement structure
18 lots · all with a published value · same evaluation weights on every lotLot #1Epoprostenol powder and solvent (pH10.5) for solution for infusion vialsRenewalPublished value£200
Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH10.5) for solution for infusion vials to NHS Scotland. The Authority intends awarding a multi-supplier unranked framework agreement for the Lot and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Lot #2Epoprostenol powder and solvent (pH12) for solution for infusion vialsAwardedRenewalPublished value£4,360,156
Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH12) for solution for infusion vials to NHS Scotland.
The Authority has awarded a multi-supplier unranked framework agreement for the Lot to a maximum of 6 Framework Participants.
Lot #3Epinepherine (Adrenaline) Pre-filled syringesAwardedRenewalPublished value£1,322,844
Supply of Epinephrine (Adrenaline) Pre-filled syringes to NHS Scotland in a range of presentations.
The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.
Lot #4Epinephrine (Adrenaline) Auto Injector DevicesRenewalPublished value£357,048
Supply of Epinephrine (Adrenaline) Auto Injector Devices to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Lot #5Enoxaparin Sodium InjectionAwardedRenewalPublished value£9,046,048
Supply of Enoxaparin Sodium Injection to NHS Scotland in a range of presentations.
The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.
Lot #6Urokinase InjectionsRenewalPublished value£228,644
Supply of Urokinase Injections to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Lot #7Isosorbide Mononitrate Modified Release Capsules and TabletsAwardedRenewalPublished value£120,484
Supply of Isosorbide Mononitrate Modified Release Capsules and Tablets to NHS Scotland in a range of presentations.
The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.
Lot #8Diltiazem Hydrochloride Modified Release Capsules and TabletsAwardedRenewalPublished value£92,152
Supply of Diltiazem Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations.
The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.
Lot #9Verapamil Hydrochloride Modified Release Capsules and TabletsAwardedRenewalPublished value£90,908
Supply of Verapamil Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations.
The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.
Lot #10Nifedipine Modified Release Capsules and TabletsAwardedRenewalPublished value£56,272
Supply of Nifedipine Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.
Lot #11Theophylline Modified Release Capsules and TabletsAwardedRenewalPublished value£27,228
Supply of Theophylline Modified Release Capsules and Tablets to NHS Scotland in a range of presentations.
The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.
Lot #12Branded and Branded Generic InhalersAwardedRenewalPublished value£2,711,720
Supply of Branded and Branded Generic Inhalers to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.
Lot #13Iloprost MedicinesAwardedRenewalPublished value£520,252
Supply of Iloprost Solutions for Infusion and Nebuliser solutions to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.
Lot #14Dalteparin InjectionAwardedRenewalPublished value£8,751,320
Supply of Dalteparin Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.
Lot #15Tinzaparin Sodium InjectionAwardedRenewalPublished value£1,354,476
Supply of Tinzaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.
Lot #16Icatibant Solution for InjectionAwardedRenewalPublished value£2,000,000
Supply of Icatibant Solution for Injection to NHS Scotland. The Authority has awarded each product line as a multi-supplier ranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.
Lot #17Tresprostinil InjectionAwardedRenewalPublished value£1,000
Supply of Treprostinil Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.
Lot #18All other Cardiovascular & Respiratory MedicinesAwardedRenewalPublished value£21,190,900
Supply of all other Cardiovascular & Respiratory Medicines to NHS Scotland in a range of presentations. Each product line was treated as an individual Lot.
The Authority has awarded each product line to a single Framework Participant.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (2)
- Logistics: 5%
- price: 95%
Published award criteria (2)
- Logistics: 5
- Price: 95
- Suitability
Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.
- Technical & professional ability
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender.
(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent at the date of submission of the tender.
(c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.
(d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.
Minimum: a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender, should be included in the Qualification Envelope of the ITT under the T…
- Price carries 95 of 100 points: a 10% discount moves about 9.5 points. This one is won on the number: sharpen the price before polishing the prose.
- “NP35923 Cardiovascular & Respiratory Medicines” is a framework: the contest is a place on its panel, not a single contract.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 11 Jan 2023, 11:36 GMT
- Last source update
- 25 Jul 2023, 10:16 BST
- Award evaluation window
- 10 Feb 2023 – …
- Authority reference
NP35923- FTS notice number
2023/S 000-021408- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-03967fFind a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Review procedure
Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:
An economic operator that suffers, or is at risk of suffering, loss or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.
The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages
Publisher note: The estimated value referred to in Section II.I.5 and within each Lot covers the twenty-four (24) months contract duration and the full twenty-four (24) months extension options of the Framework Agreement. The Goods within this procurement were separated and advertised as eighteen (18) categories, each of which was identified as a “Lot”. Out of the 18 lots, 15 Lots have been awarded. For details of lots not awarded, or details of individual lines awarded within a lot contact the named person at head of notice. (SC Ref:737798)
How it was run
Official notice- Appointment period ends
- 10 Feb 2023, 17:00 GMT
- Submission channel
- {"electronicSubmission"}
- Accepted languages
- en
- Bid validity
- 90 days from the deadline
- Bids opened
- 10 Feb 2023, 17:00 GMT
Timeline
10 Feb 2023 → 25 Jul 2023 · 3 dates- Admission / appointment period endsperiod end, not a bid countdown10 Feb 2023, 17:00 GMT
- Bids opened10 Feb 2023, 17:00 GMT
- Notice published25 Jul 2023, 10:16 BST
Notice history
1 event · 2 releases on Find a Tender- Status changed to complete25 Jul 2023, 10:16 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast15 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Epoprostenol powder and solvent (pH12) for solution for infusion vials
- Signed
- 3 Apr 2023
- Value
- £4,360,152
- Status
- active
Iloprost Medicines
- Signed
- 3 Apr 2023
- Value
- £687,053
- Status
- active
Dalteparin Injection
- Signed
- 3 Apr 2023
- Value
- £13,611,251
- Status
- active
Tinzaparin Sodium Injection
- Signed
- 3 Apr 2023
- Value
- £1,354,476
- Status
- active
Icatibant Solution for Injection
- Signed
- 3 Apr 2023
- Value
- £95,013
- Status
- active
Tresprostinil Injection
- Signed
- 3 Apr 2023
- Value
- £89,320
- Status
- active
All other Cardiovascular & Respiratory Medicines
- Signed
- 3 Apr 2023
- Value
- £18,729,687
- Status
- active
Epinepherine (Adrenaline) Pre-filled syringes
- Signed
- 3 Apr 2023
- Value
- £714,020
- Status
- active
Enoxaparin Sodium Injection
- Signed
- 3 Apr 2023
- Value
- £10,095,071
- Status
- active
Isosorbide Mononitrate Modified Release Capsules and Tablets
- Signed
- 3 Apr 2023
- Value
- £42,957
- Status
- active
Diltiazem Hydrochloride Modified Release Capsules and Tablets
- Signed
- 3 Apr 2023
- Value
- £58,174
- Status
- active
Verapamil Hydrochloride Modified Release Capsules and Tablets
- Signed
- 3 Apr 2023
- Value
- £24,024
- Status
- active
Nifedipine Modified Release Capsules and Tablets
- Signed
- 3 Apr 2023
- Value
- £8,693
- Status
- active
Theophylline Modified Release Capsules and Tablets
- Signed
- 3 Apr 2023
- Value
- £25,699
- Status
- active
Branded and Branded Generic Inhalers
- Signed
- 3 Apr 2023
- Value
- £3,451,061
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 2 · Epoprostenol powder and solvent (pH12) for solution for infusion vials | 1bids · 1 electronic · 1 from abroad | 0 | — | — |
| 3 · Epinepherine (Adrenaline) Pre-filled syringes | 1bids · 1 electronic · 1 from abroad | 1 | — | — |
| 5 · Enoxaparin Sodium Injection | 6bids · 6 electronic · 6 from abroad | 4 | — | — |
| 7 · Isosorbide Mononitrate Modified Release Capsules and Tablets | 5bids · 5 electronic · 5 from abroad | 5 | — | — |
| 8 · Diltiazem Hydrochloride Modified Release Capsules and Tablets | 4bids · 4 electronic · 4 from abroad | 4 | — | — |
| 9 · Verapamil Hydrochloride Modified Release Capsules and Tablets | 1bids · 1 electronic · 1 from abroad | 1 | — | — |
| 10 · Nifedipine Modified Release Capsules and Tablets | 3bids · 3 electronic · 3 from abroad | 3 | — | — |
| 11 · Theophylline Modified Release Capsules and Tablets | 1bids · 1 electronic · 1 from abroad | 1 | — | — |
| 12 · Branded and Branded Generic Inhalers | 12bids · 12 electronic · 12 from abroad | 10 | — | — |
| 13 · Iloprost Medicines | 2bids · 2 electronic · 2 from abroad | 1 | — | — |
| 14 · Dalteparin Injection | 1bids · 1 electronic · 1 from abroad | 1 | — | — |
| 15 · Tinzaparin Sodium Injection | 1bids · 1 electronic · 1 from abroad | 1 | — | — |
| 16 · Icatibant Solution for Injection | 6bids · 6 electronic · 6 from abroad | 5 | — | — |
| 17 · Tresprostinil Injection | 2bids · 2 electronic · 2 from abroad | 2 | — | — |
| 18 · All other Cardiovascular & Respiratory Medicines | 43bids · 43 electronic · 43 from abroad | 32 | — | — |
Contracting authority & participating public bodies
Framework contractors & participating bidders
46 commercial parties on the notice- AOP Orphan LtdFramework contractor
- Accord-UK LtdFramework contractor
- Aguettant LtdFramework contractor
- Aspire Pharma LtdFramework contractor
- Aventis Pharma Ltd Trading As SanofiFramework contractor
- Baxter Healthcare LtdFramework contractor
- Beaumont Pharma LtdFramework contractor
- Bowmed Ibisqus LimitedFramework contractor
- CST Pharma LtdFramework contractor
- Chiesi LimitedFramework contractor
Show 36 more suppliers
- Colonis Pharma LtdFramework contractor
- Consilient Health LtdFramework contractor
- Correvio GmbHFramework contractor
- Crescent Pharma LimitedFramework contractor
- Day Lewis Medical LtdFramework contractor
- Dr Reddy's Laboratories (UK) LtdFramework contractor
- Ennogen Healthcare LtdFramework contractor
- Esteve Pharmaceuticals LtdFramework contractor
- Focus Pharmaceuticals LtdFramework contractor
- Galen LtdFramework contractor
- GlaxoSmithKlineFramework contractor
- Glenmark Pharmaceuticals Europe LtdFramework contractor
- Kent Pharmaceuticals LtdFramework contractor
- LEO PharmaFramework contractor
- Lupin (Europe) LimitedFramework contractor
- Martindale PharmaFramework contractor
- Mercury Pharma GroupFramework contractor
- Morningside Pharmaceuticals LimitedFramework contractor
- Neon HealthcareFramework contractor
- P M Pharma LtdFramework contractor
- Pfizer LtdFramework contractor
- ROVI Biotech LimitedFramework contractor
- RPH Pharma LtdFramework contractor
- Ranbaxy UK LtdFramework contractor
- Rosemont Pharmaceuticals LtdFramework contractor
- Sandoz LtdFramework contractor
- Selective Supplies LtdFramework contractor
- Synchrony Pharma LtdFramework contractor
- Techdow Pharma England LtdFramework contractor
- Tetris Pharma LtdFramework contractor
- Teva UK LimitedFramework contractor
- Thornton & RossFramework contractor
- Viatris UK Healthcare LtdFramework contractor
- Wockhardt UK LimitedFramework contractor
- Zentiva Pharma UK LtdFramework contractor
- hameln pharma ltdFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.